Palvella Therapeutics, Inc.
PVLA
$50.13
-$3.29-6.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 70.43M | 75.63M | 83.60M | 14.21M | 14.54M |
| Total Receivables | 1.98M | 1.98M | 2.34M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.34M | 1.84M | 2.30M | 441.00K | 307.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 1.67M | 500.00K |
| Total Current Assets | 73.75M | 79.44M | 88.23M | 16.32M | 15.34M |
|
|
|||||
| Total Current Assets | 73.75M | 79.44M | 88.23M | 16.32M | 15.34M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 73.75M | 79.44M | 88.23M | 16.32M | 15.34M |
|
|
|||||
| Total Accounts Payable | 4.56M | 4.44M | 4.59M | 3.13M | 1.45M |
| Total Accrued Expenses | 2.16M | 1.74M | 4.29M | 4.22M | 2.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.90M | 2.80M | 3.17M | 282.00K | 231.00K |
| Total Other Current Liabilities | 2.90M | 2.80M | 3.17M | 282.00K | 231.00K |
| Total Current Liabilities | 9.62M | 8.98M | 12.04M | 7.64M | 4.40M |
|
|
|||||
| Total Current Liabilities | 9.62M | 8.98M | 12.04M | 7.64M | 4.40M |
| Long-Term Debt | 14.51M | 13.16M | 11.94M | 24.07M | 19.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.84M | 1.72M | 1.65M | 1.42M | 1.34M |
| Total Liabilities | 25.97M | 23.86M | 25.63M | 33.12M | 25.57M |
|
|
|||||
| Common Stock & APIC | 159.28M | 157.50M | 156.34M | 2.38M | 2.18M |
| Retained Earnings | -111.39M | -101.92M | -93.74M | -89.78M | -83.01M |
| Treasury Stock & Other | -111.00K | -3.00K | 3.00K | -- | -- |
| Total Common Equity | 47.78M | 55.58M | 62.61M | -87.40M | -80.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 70.60M | 70.60M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 70.60M | 70.60M |
|
|
|||||
| Total Common Equity | 47.78M | 55.58M | 62.61M | -87.40M | -80.83M |
| Total Preferred Equity | -- | -- | -- | 70.60M | 70.60M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 47.78M | 55.58M | 62.61M | -16.80M | -10.23M |
|
|
|||||